Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.
Showing 8601–8650 of 18655
announced that Uneek Mehra had joined the Company as Chief Financial and Business Officer, Principal Financial Officer, Principal Accounting Officer, and Assistant Secretary of the Company.
announced that August J. Moretti will retire as Chief Financial Officer and Assistant Secretary of the Company, effective September 11, 2023.
Marc Montagner has been appointed to serve as the Executive Vice President & Chief Financial Officer of the Company (the “CFO”) to succeed Mr. Brendan Cavanagh, effective January 1, 2024.
Mr. Cavanagh, currently the Company’s Executive Vice President & Chief Financial Officer, will succeed Mr. Jeffrey Stoops as President and Chief Executive Officer, effective January 1, 2024.
Mr. Cavanagh, currently the Company’s Executive Vice President & Chief Financial Officer, will succeed Mr. Jeffrey Stoops as President and Chief Executive Officer, effective January 1, 2024.
the Board appointed Brandon L. Brown, Sr. as the Company’s Senior Vice President and Chief Financial Officer, effective as of September 27, 2023
On September 7, 2023, Mr. Salah Gamoudi notified the Board of Directors (the “Board”) of SandRidge Energy, Inc. (the “Company”) that he is resigning as the Company’s Executive Vice President and Chief Financial Officer effective September 27, 2023 (the “Resignation”), to pursue other opportunities.
The Board of Directors (the “Board”) of Madrigal Pharmaceuticals, Inc. (the “Company”) appointed Bill Sibold as the President and Chief Executive Officer of the Company, increased the Board size to nine and appointed Bill Sibold as a member of the Board, in each case effective as of 5:01 p.m. ET on September 8, 2023 (the “Start Date”).
As of the Start Date, Dr. Friedman stepped down as Chief Executive Officer but will continue to serve as a director of the Company.
The Company expects to appoint John Lanza, age 53, as Interim Chief Financial Officer and Interim Treasurer of the Company, subject to approval by the board of directors of the Company, if a permanent successor to Mr. Pessah is not identified by November 10, 2023.
On September 7, 2023, David Pessah notified Goldman Sachs BDC, Inc. (the “Company”) of his intention to resign as Chief Financial Officer, Treasurer and principal accounting officer of the Company to pursue a new professional opportunity.
The Company expects to appoint John Lanza, age 53, as Interim Chief Financial Officer and Interim Treasurer of the Company, subject to approval by the board of directors of the Company, if a permanent successor to Mr. Pessah is not identified by November 10, 2023.
On September 7, 2023, David Pessah notified Goldman Sachs Private Middle Market Credit LLC (the “Company”) of his intention to resign as Chief Financial Officer, Treasurer and principal accounting officer of the Company to pursue a new professional opportunity.
On September 7, 2023, David Pessah notified Goldman Sachs Private Middle Market Credit II LLC (the “Company”) of his intention to resign as Chief Financial Officer, Treasurer and principal accounting officer of the Company to pursue a new professional opportunity.
The Company expects to appoint John Lanza, age 53, as Interim Chief Financial Officer and Interim Treasurer of the Company, subject to approval by the board of directors of the Company, if a permanent successor to Mr. Pessah is not identified by November 10, 2023.
The Company expects to appoint John Lanza, age 53, as Interim Chief Financial Officer and Interim Treasurer of the Company, subject to approval by the board of directors of the Company, if a permanent successor to Mr. Pessah is not identified by November 10, 2023.
On September 7, 2023, David Pessah notified Goldman Sachs Middle Market Lending Corp. II (the “Company”) of his intention to resign as Chief Financial Officer, Treasurer and principal accounting officer of the Company to pursue a new professional opportunity.
The Company expects to appoint John Lanza, age 53, as Interim Chief Financial Officer and Interim Treasurer of the Company, subject to approval by the board of directors of the Company, if a permanent successor to Mr. Pessah is not identified by November 10, 2023.
On September 7, 2023, David Pessah notified Goldman Sachs Private Credit Corp. (the “Company”) of his intention to resign as Chief Financial Officer, Treasurer and principal accounting officer of the Company to pursue a new professional opportunity.
The Company expects to appoint John Lanza, age 53, as Interim Chief Financial Officer and Interim Treasurer of the Company, subject to approval by the board of directors of the Company, if a permanent successor to Mr. Pessah is not identified by November 10, 2023.
On September 7, 2023, David Pessah notified Phillip Street Middle Market Lending Fund LLC (the “Company”) of his intention to resign as Chief Financial Officer, Treasurer and principal accounting officer of the Company to pursue a new professional opportunity.
On September 8, 2023, effective immediately, the following officers submitted the resignation of their respective offices: Daniel Braatz as Chairman of the Board and Chief Executive Officer and Xavier Martinez as Chief Financial Officer.
On September 8, 2023, effective immediately, the following officers submitted the resignation of their respective offices: Daniel Braatz as Chairman of the Board and Chief Executive Officer and Xavier Martinez as Chief Financial Officer.
On September 13, 2023, Charlotte’s Web Holdings, Inc. (the “Company”) announced the appointment of William Morachnick, age 59, as the Company’s Chief Executive Officer effective immediately.
Mr. Morachnick will replace the Company’s Chief Executive Officer, Jacques Tortoroli, who will depart the Company effective September 13, 2023.
On September 5, 2023, the Company appointed Bennett Buchanan, a director of the Company and the Company’s COO prior to his appointment, to serve as the Company’s Chief Executive Officer, Secretary and Treasurer.
On September 13, 2023, SKYX Platforms Corp. (the “Company”) announced that on September 12, 2023, its Board of Directors (the “Board”) appointed Leonard J. Sokolow as Co-Chief Executive Officer of the Company, effective immediately .
On July 25, 2023, Kelly Wilson, Chief Executive Officer and Chief Operating Officer of Company, delivered a letter of resignation to the Company, pursuant to which Ms. Wilson resigned as Chief Executive Officer of the Company, effective immediately.
On July 25, 2023, the Board of the Company appointed Noreen Griffin as Chief Executive Officer.
On September 7, 2023, the Board of Directors (the “Board”) of NantHealth, Inc. (the “Company”) appointed Rao Haris Naseem, M.D., FACC, FHRS as the Company’s Chief Executive Officer (“CEO”) and a member of the Board, effective September 7, 2023 (the “Effective Date”).
On September 11, 2023, following Mr. Matruski 's resignation pursuant to the cancellation agreement, the Company appointed Mr. Roy Watson as its President and CEO , effectively immediately.
On September 11, 2023, Mr. Adam Matruski resigned from the positions of the President and CEO, Director, Secretary, and Treasurer of the Company.
On September 6, 2023, the Company and the Bank received and accepted the resignation of President and Chief Executive Officer Kevin J. Lycklama.
On September 11, 2023, Geron Corporation (“Geron” or the “Company”) announced the appointment of Michelle J. Robertson as Executive Vice President, Chief Financial Officer and Treasurer, effective September 25, 2023, succeeding Olivia K. Bloom, who will retire from that role with the Company on that date.
On September 11, 2023, Geron Corporation (“Geron” or the “Company”) announced the appointment of Michelle J. Robertson as Executive Vice President, Chief Financial Officer and Treasurer, effective September 25, 2023, succeeding Olivia K. Bloom, who will retire from that role with the Company on that date.
the Company and Deverl Maserang, the Company’s President and Chief Executive Officer, had agreed that Mr. Maserang’s employment with the Company would be terminated, without cause, effective September 30, 2023.
Effective upon the closing of the Merger on September 12, 2023, Mr. Weil resigned from his position with the Company.
Effective upon the closing of the Merger, on September 12, 2023, Mr. Anderson began serving as the Company’s chief-executive officer.
Edward M. Weil, Jr., who has served as a member of our Board since 2017, was appointed as Co-Chief Executive Officer of GNL
James L. Nelson, who has served as our Chief Executive Officer prior to the Transactions and will continue with Mr. Weil as Co-Chief Executive Officer.
including the RTL Restricted Shares held by the Company’s directors, and those held by Jason Doyle, who served as the Company’s Chief Financial Officer prior to the REIT Merger.
Michael Anderson was appointed to serve as the Company’s chief executive officer and Joseph Marnikovic was appointed to serve as the Company’s chief financial officer.
Effective upon the closing of the Merger on September 12, 2023, each of Messrs. Weil and Masterson resigned from their positions with the Company.
Michael Anderson was appointed to serve as the Company’s chief executive officer and Joseph Marnikovic was appointed to serve as the Company’s chief financial officer.
Effective upon the closing of the Merger on September 12, 2023, each of Messrs. Weil and Masterson resigned from their positions with the Company.
Effective as of October 1, 2023, Patricia Carr, the Company’s Senior Vice President and Chief Accounting Officer, will serve as the Company’s principal financial officer on an interim basis while the Company conducts a search for Ms. Galá’s replacement as the Company’s Executive Vice President and Chief Financial Officer.
replacing Jon Snodgres, who tendered his intention to retire on September 8, 2023 and who will continue in a full-time advisory role with the Company until October 6, 2023.
On September 12, 2023, Repligen Corporation (the “Company”) announced that Jason K. Garland would be joining the Company as its Chief Financial Officer, effective September 25, 2023 (the “Effective Date”), replacing Jon Snodgres, who tendered his intention to retire on September 8, 2023 and who will continue in a full-time advisory role with the Company until October 6, 2023.
On September 8, 2023, Kristian Humer, the Chief Financial Officer and Chief Business Officer of Viridian Therapeutics, Inc. (the “Company”), resigned, effective September 12, 2023.
on September 12, 2023, Seth Harmon, the Company’s Senior Vice President of Finance, assumed the role of the Company’s principal financial and accounting officer.
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.